亚盛医药集团（06855）于2026年2月5日披露1月份股份变动月报。报告期截至2026年1月31日，公司法定注册股本维持在500,000,000股（面值每股0.0001美元），总额50,000美元，未发生变动。
报告显示，普通股股份数量由上月底的373,321,692股增至373,322,192股，增幅500股，主要源自“首次公开发售前购股权计划”行使期权后新发行的500股。本月内不存在股份回购、注销或库藏股变动。
期权与激励方面，“首次公开发售前购股权计划”月初结余2,152,227股期权，本月行使500股后余额为2,151,727股；“首次公开发售后购股权计划”月末可发行或转让合计14,170,855股。公司确认各项发行及相关事宜已获得董事会正式授权，并遵守香港联交所上市规则及其他法律法规。
公告由公司秘书陈焯墁签署。报告期末，公司股本结构整体维持稳定。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.